Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki M S
Department of Orthopaedic Surgery, Faculty of Medicine, Kyoto University, Japan.
Anticancer Res. 1996 Jul-Aug;16(4A):2009-15.
Loss of heterozygosity (LOH) of chromosomes 13q and 17p and mutations of the retinoblastoma (Rb) and p53 gene were studied in 28 tumors from 22 patients with chondrosarcomas. Allele loss at polymorphic loci on 13q was found in 36% of tumors and the frequency was much higher in grade II (56%) or high grade (40%) tumors than in grade I tumors (18%). LOH of 17p, which was detected in 25% of all tumors, was of low frequency in low grade tumors (8% in grade I and 20% in grade II), whereas 80% of tumors with high grade tumors were positive for LOH. These observations may imply that LOH on 13q and 17p contributes to the tumor development at different stages. In low grade cases (grade I and II), tumor recurrence was observed more frequently in primary tumors with LOH on 13q (86%) than those without (8%), suggesting the significance of LOH analysis in the assessment of biological behavior of tumors. Structural alteration of the Rb gene was found in one dedifferentiated tumor, and point mutations of the p53 gene were found in all of five high grade tumors, indicating that high grade chondrosarcomas were genetically equivalent to other high grade sarcomas such as osteosarcomas.
对22例软骨肉瘤患者的28个肿瘤进行了13号染色体长臂(13q)和17号染色体短臂(17p)的杂合性缺失(LOH)以及视网膜母细胞瘤(Rb)和p53基因的突变研究。在36%的肿瘤中发现了13q多态性位点的等位基因缺失,其在Ⅱ级(56%)或高级别(40%)肿瘤中的频率远高于Ⅰ级肿瘤(18%)。17p的LOH在所有肿瘤中的检出率为25%,在低级别肿瘤中频率较低(Ⅰ级为8%,Ⅱ级为20%),而高级别肿瘤中有80%的肿瘤17p的LOH呈阳性。这些观察结果可能意味着13q和17p的LOH在肿瘤发展的不同阶段发挥作用。在低级别病例(Ⅰ级和Ⅱ级)中,13q存在LOH的原发性肿瘤(86%)比无LOH的原发性肿瘤(8%)更频繁地出现肿瘤复发,提示LOH分析在评估肿瘤生物学行为中的意义。在1例去分化肿瘤中发现了Rb基因的结构改变,在所有5个高级别肿瘤中均发现了p53基因的点突变,表明高级别软骨肉瘤在遗传学上与骨肉瘤等其他高级别肉瘤相当。